首页> 外国专利> Use of Salmonella enterica ssp. enterica serovar Typhimurium antigens for serological differentiation of infected and vaccinated pigs

Use of Salmonella enterica ssp. enterica serovar Typhimurium antigens for serological differentiation of infected and vaccinated pigs

机译:使用沙门氏菌小肠沙门氏菌。肠炎血清鼠伤寒抗原用于感染猪和疫苗接种猪的血清学区分

摘要

In the present invention, there is described a method of serological differentiation of pigs infected by Salmonella enterica ssp. enterica sérovar Typhimurium from pigs vaccinated with a vaccine based on an inactivated culture of Salmonella enterica ssp. enterica sérovar Typhimurium. The invention is characterized in that using the ELISA or westernblot method a level of antibodies against at least one native or recombinant protein being selected from the group consisting of SseB, Gene ID: 1252916; SipB, Gene ID: 1254408 and SipD, Gene ID: 1254406, and at least one native or recombinant protein being selected from the group consisting of FliC, Gene ID: 1253480 and YfgL, Gene ID: 1254042, is determined in a serum sample. The infected animals are identified in such a manner that if compared with vaccinated animals they have a higher level of antibodies against the SseB or SipB or SipD protein and at the same time, they have a lower level of antibodies against the FliC or YfgL protein. On the other hand, the vaccinated animals are identified in such a manner that if compared with infected animals, they have a higher level of antibodies against the FliC or YfgL protein and at the same time a lower level of antibodies against the SseB or SipB or SipD protein. The serological differentiation of infected and vaccinated pigs is necessary for selecting therapeutic processes resulting in the reduction of percentage of the Salmonella positive slaughter pigs. Another reason for the necessity of differentiation of infected and vaccinated animals is the exclusion of a false positivism of the vaccinated pigs when assessing contamination of the piggeries with Salmonella ssp. Using so far known serological methods in some Western European countries.
机译:在本发明中,描述了一种被肠炎沙门氏菌感染的猪的血清学分化方法。猪肠炎沙门氏菌(S.roro Typhimurium)来自接种了基于肠炎沙门氏菌灭活培养物的疫苗的疫苗。肠沙门氏菌。本发明的特征在于,使用ELISA或westernblot方法,针对至少一种天然或重组蛋白的抗体水平选自SseB,基因ID:1252916;和SseB。在血清样品中测定SipB,基因ID:1254408和SipD,基因ID:1254406,以及选自FliC,基因ID:1253480和YfgL,基因ID:1254042的至少一种天然或重组蛋白。以这样的方式鉴定受感染的动物:与疫苗接种的动物相比,它们具有较高水平的针对SseB或SipB或SipD蛋白的抗体,同时具有较低水平的针对FliC或YfgL蛋白的抗体。另一方面,以这样的方式鉴定疫苗接种的动物:与感染的动物相比,它们具有较高水平的针对FliC或YfgL蛋白的抗体,同时具有较低水平的针对SseB或SipB或SipB的抗体。 SipD蛋白。感染猪和疫苗接种猪的血清学差异对于选择治疗方法是必要的,从而降低沙门氏菌阳性屠宰猪的百分比。必须区分感染和接种疫苗的动物的另一个原因是,在评估猪沙门氏菌对猪的污染时,排除了接种猪的假阳性。在某些西欧国家使用迄今已知的血清学方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号